methylprednisolone hemisuccinate has been researched along with Cranial Nerve II Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cannon, TC; Davis, P; Flynn, S; Lovelace, K; Schmucker, T; Westfall, CT | 1 |
| DeLuca, J; Frohman, L; Krieger, A; Mauriello, JA; Schulder, M | 1 |
2 other study(ies) available for methylprednisolone hemisuccinate and Cranial Nerve II Diseases
| Article | Year |
|---|---|
Optic neuropathy in patient with Wegener's granulomatosis.
Topics: Adult; Granulomatosis with Polyangiitis; Humans; Male; Methylprednisolone Hemisuccinate; Neuroprotective Agents; Optic Nerve Diseases; Orbit; Tomography, X-Ray Computed | 2004 |
Management of traumatic optic neuropathy--a study of 23 patients.
Topics: Adolescent; Adult; Combined Modality Therapy; Eye Hemorrhage; Eye Injuries; Female; Hematoma; Humans; Male; Methylprednisolone Hemisuccinate; Middle Aged; Optic Nerve; Optic Nerve Diseases; Tomography, X-Ray Computed | 1992 |